DC Chemicals Limited
China
Product Name: Clamikalant sodium
Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/1g
Purity: 98.0%
Stocking Period: 3 Day
Contact: Tony Cao
Email: sales@dcchemicals.com

261717-22-0

261717-22-0 structure

Name: Clamikalant sodium
Chemical Name: Sodium (5-chloro-2-methoxybenzoyl)(2-{4-methoxy-3-[(methylcarbamo thioyl)sulfamoyl]phenyl}ethyl)azanide
CAS Number: 261717-22-0
Molecular Formula: C₁₉H₂₁ClN₃NaO₅S₂
Molecular Weight: 493.96000
Catalog: Signaling Pathways Membrane Transporter/Ion Channel Potassium Channel
Create Date: 2017-09-08 16:41:50
Modify Date: 2024-01-12 17:09:27
Clamikalant sodium (HMR 1098) is an ATP-sensitive potassium (KATP) channel blocker. Clamikalant sodium can be used for the research of arrhythmia[1].

Name	Sodium (5-chloro-2-methoxybenzoyl)(2-{4-methoxy-3-[(methylcarbamo thioyl)sulfamoyl]phenyl}ethyl)azanide

Description	Clamikalant sodium (HMR 1098) is an ATP-sensitive potassium (KATP) channel blocker. Clamikalant sodium can be used for the research of arrhythmia[1].
Related Catalog	Research Areas >> Neurological Disease Signaling Pathways >> Membrane Transporter/Ion Channel >> Potassium Channel
In Vitro	Clamikalant sodium (HMR 1098; 40 μM) prevents improvement effect of Levosimendam on left ventricular developed pressure (LVDP) recovery rate, abolishes the inhibitory effect of Levosimendan on hypothermic preservation-induced activation of calpain, cleavage of Bid, and apoptosis[2]. Clamikalant sodium (HMR 1098; 30 µM, 24 hours) reduces cellular viability, increases the apoptosis of Neonatal rat cardiomyocytes (NRCs) [3]. Clamikalant sodium (30 µM) decreases the Bcl-2 protein level and increases the Bax protein level in the LPS-exposed NRCs[3]. Cell Viability Assay[3] Cell Line: Neonatal rat cardiomyocytes (NRCs) Concentration: 30 µM Incubation Time: 24 hours Result: Reduced cellular viability to 42.8±6.3% compared with the LPS group. Western Blot Analysis[3] Cell Line: Neonatal rat cardiomyocytes (NRCs) Concentration: 30 µM Incubation Time: 24 hours Result: Decreased the Bcl-2 protein level and increased the Bax protein level.
In Vivo	Clamikalant sodium (HMR 1098; 6.0 mg/kg; 5 min prior to EET administration) completely abolishes the cardioprotection produced by epoxyeicosatrienoic acid (EET)[1].
References	[1]. Garrett J Gross, et al. Roles of endothelial nitric oxide synthase (eNOS) and mitochondrial permeability transition pore (MPTP) in epoxyeicosatrienoic acid (EET)-induced cardioprotection against infarction in intact rat hearts. J Mol Cell Cardiol. 2013 Jun;59:20-9. [2]. Hai-yan Zhou, et al. Improved myocardial function with supplement of levosimendan to Celsior solution. J Cardiovasc Pharmacol. 2014 Sep;64(3):256-65. [3]. Xiaohui Zhang, et al. Sarcolemmal ATP-sensitive potassium channel protects cardiac myocytes against lipopolysaccharide-induced apoptosis. Int J Mol Med. 2016 Sep;38(3):758-66.

Molecular Formula	C₁₉H₂₁ClN₃NaO₅S₂
Molecular Weight	493.96000
Exact Mass	493.05100
PSA	141.24000
LogP	4.77940

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

261717-22-0	61618-27-7
1192491-61-4	69388-84-7
16482-55-6	30605-57-3
61538-65-6	54600-91-8
88911-12-0	54807-39-5
2227723-40-0	2228055-79-4
2228239-58-3	1337171-11-5
2229098-89-7	2229131-81-9
2229540-22-9	2228239-61-8
2227916-77-8	2229540-30-9